Reassessing the safety of varenicline.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.Addiction (Abingdon, England) · 2016
   Pooled it
2. Weight gain and 10-year cardiovascular risk with sustained tobacco abstinence in smokers with serious mental illness: a subgroup analysis of a randomized trial.The Journal of clinical psychiatry · 2016
   Trial
3. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.JAMA · 2014
   Trial
4. Association Between Conflicts of Interest and Authors' Positions on Harms of Varenicline: a Cross-Sectional Analysis.Journal of general internal medicine · 2022
   Article
5. Rates of retention of persons with a mental health disorder in outpatient smoking cessation and reduction trials, and associated factors: protocol for a systematic review and meta-analysis.BMJ open · 2019
   Article
6. Need for Cardiovascular Risk Reduction in Persons With Serious Mental Illness: Design of a Comprehensive Intervention.Frontiers in psychiatry · 2018
   Article
7. Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations.CNS drugs · 2017
   Review
8. Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.Schizophrenia bulletin · 2016
   Review
9. The First Published Case Report of an Adult Woman Who Developed Suicidal Ideation as an Adverse Event Related to Methylphenidate Use.The primary care companion for CNS disorders · 2015
   Article
10. Cancer screening, prevention, and treatment in people with mental illness.CA: a cancer journal for clinicians
    Review
11. Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices.Harvard review of psychiatry
    Review

Corrections and comments

• Comment on
  Varenicline, smoking cessation, and neuropsychiatric adverse events.2013

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as